Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal macrophages are specialized tissue-resident immune cells of the mononuclear phagocyte lineage found predominantly in the gut lamina propria, submucosa, and muscularis externa. They constitute the most abundant population of macrophages in the body and are critical for the maintenance of gut homeostasis. Their main functions include phagocytosis of pathogens and apoptotic cells, immune regulation, limiting inflammation, promoting wound healing, and facilitating crosstalk between immune, epithelial, neuronal, and vascular cells in the gastrointestinal tract. They differ from conventional macrophages in other tissues by their strong anti-inflammatory phenotype, ability to tolerate commensal bacteria, and niche-specific functional specialization. Aberrant macrophage responses are implicated in diseases such as IBD and other inflammatory or infectious diseases of the gut. However, “intestinal macrophage” is not a molecular target or receptor, but rather a physiological population of immune cells described by surface markers and location, and cannot be directly targeted in the way individual proteins or receptors are in drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal macrophage.